Securing robust funding increases for medical research, preserving the R&D tax credit and preventing caps on indirect costs for research are among the accomplishments of research advocates in 2017 – a year in which strategic and innovative advocacy made a difference.
The $2 billion increase for the National Institutes of Health (NIH) in FY17 demonstrated the ongoing commitment of policymakers to capitalize on the power of research to meet American objectives.
“The investments we make in NIH research will not only save lives, they’ll lead to new frontiers in drug and device development that are critical for reducing health care costs, growing our economy, and maintaining America’s competitive edge in innovation,” said Senator Roy Blunt (R-MO), chairman of the Senate Labor-HHS-Education subcommittee.
Congressional passage of crucial FDA user fees, and sustained funding for the Agency for Healthcare Research and Quality, Department of Defense medical research and global health research capacity were also important steps to advance life-saving research from discovery, development to delivery.
In the new year, Research!America will continue to fight for the funding needed to speed medical progress and a policy climate in which public and private sector innovation thrive. Support for patient-centered research and efforts to strengthen public health, prevention and global health initiatives will be front-and-center, as major health challenges from the opioid epidemic, cancer to Alzheimer’s disease inflict damage on the health and economic prosperity of our nation.
For the midterm elections, all 435 seats in the House and 33 in the Senate will be up for grabs. As elected officials and challengers stump for votes, Research!America will help empower scientists and other research advocates to engage with candidates to elevate research for health in the national conversation.
In a survey commissioned by Research!America, many Americans agree that scientists should play a role in shaping public policy on issues ranging from medical and health research to education, energy and our nation’s infrastructure.
“In order for science to have a more prominent position in our national agenda, the public and their policymakers must hear more from scientists about the health and economic benefits of public and private sector research,” said Research!America president and CEO Mary Woolley.